Share Twitter LinkedIn Facebook Email VITALY MARGULIS MD ASSOCIATE PROFESSOR UROLOGIC ONCOLOGY of UT Southwestern discusses NEOADJUVANT THERAPY PRIOR TO SURGERY at the Kidney Cancer Association National Patient and Caregiver Conference Chicago, IL September 22, 2018
Tivozanib for RCC: Unpacking Efficacy, Safety, and Dose Optimization – Bradley McGregor, MD – Dana Farber Genitourinary 3 Mins Read
Renal Cell Carcinoma TiNivo-2 Study: Patient-Reported Outcomes in Treatment Post-ICI Kidney 3 Mins Read
VIDEO: FDA Approves Atezolizumab / Tecentriq Hybreza For Subcutaneous PD-(L)1 Cancer Immunotherapy in NSCLC Kidney 4 Mins Read